Figure 7

Impact of treatment sequence with bevacizumab and radiation. Six groups of mice with SCC1 and H226 tumors were treated with: IgG (control), bevacizumab (B), radiation (X), concurrent bevacizumab and radiation (B/X), bevacizumab followed by radiation (B⇒X), and radiation followed by bevacizumab (X⇒B). (A) Treatment schedule, and tumor growth inhibition in (B) SCC1 and (C) H226 models (n = 16 tumors per treatment group for each cell line).